Chun-Yuan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chun-Yuan Chen has a total of 221 co-authors. Here are the top co-authors by number of shared publications:
- Hui Xie
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
22 shared publications Hao Yin
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
18 shared publicationsYi-Juan Tan
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
14 shared publicationsShan-Shan Rao
Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, China
12 shared publicationsJia Cao
Department of Orthopedics Movement System Injury and Repair Research Center Xiangya Hospital Central South University Changsha Hunan China
11 shared publicationsZe-Hui He
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
10 shared publications
Latest Publications
- RetractionOpen Access
- 27 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9152
Retraction Note: Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
- 27 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9152
RetractionOpen AccessRetraction Note: Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
- Open Access
- 13 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (44) , e23067
Amuc_1473 Links Gut Microbes to Skeletal Homeostasis and Counteracts Multifactorial Osteoporosis
Emerging evidence suggests that gut microbiota‐derived signals can influence distant organs including the skeleton, yet the key microbial effectors remain elusive. Here, we identify Amuc_1473, a previously uncharacterized protein enriched in extracellular vesicles (EVs) from the commensal bacterium Akkermansia muciniphila ( Akk ), as a critical mediator of gut–bone communication. Amuc_1473 directly promotes osteogenesis and suppresses osteoclastogenesis by binding to negative elongation factor E (NELF‐E) and ribosomal protein L26 (RPL26), regulators of transcriptional pausing and mRNA translation, respectively. Notably, Amuc_1473 levels decline in bone and circulation under diverse pro‐osteoporotic conditions—including aging, estrogen deficiency, mechanical unloading, high‐fat diet, smoking, alcohol, and chronic stress—paralleling reductions in Akk and its EVs. Intermittent fasting robustly restores Akk abundance, Amuc_1473 levels, and bone quality in these models, via enhanced mucin production. Our findings establish Amuc_1473 as a microbial effector that systemically regulates bone homeostasis, offering a translatable strategy to prevent or treat multifactorial osteoporosis.
- 13 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (44) , e23067
Open AccessAmuc_1473 Links Gut Microbes to Skeletal Homeostasis and Counteracts Multifactorial Osteoporosis
Emerging evidence suggests that gut microbiota‐derived signals can influence distant organs including the skeleton, yet the key microbial effectors remain elusive. Here, we identify Amuc_1473, a previously uncharacterized protein enriched in extracellular vesicles (EVs) from the commensal bacterium Akkermansia muciniphila ( Akk ), as a critical mediator of gut–bone communication. Amuc_1473 directly promotes osteogenesis and suppresses osteoclastogenesis by binding to negative elongation factor E (NELF‐E) and ribosomal protein L26 (RPL26), regulators of transcriptional pausing and mRNA translation, respectively. Notably, Amuc_1473 levels decline in bone and circulation under diverse pro‐osteoporotic conditions—including aging, estrogen deficiency, mechanical unloading, high‐fat diet, smoking, alcohol, and chronic stress—paralleling reductions in Akk and its EVs. Intermittent fasting robustly restores Akk abundance, Amuc_1473 levels, and bone quality in these models, via enhanced mucin production. Our findings establish Amuc_1473 as a microbial effector that systemically regulates bone homeostasis, offering a translatable strategy to prevent or treat multifactorial osteoporosis.
- Open Access
- 27 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103289
BMSC-targeting aptamer conjugation enhances bone delivery of a rice bran peptide to mitigate osteoporosis via eIF3L
- 27 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103289
Open AccessBMSC-targeting aptamer conjugation enhances bone delivery of a rice bran peptide to mitigate osteoporosis via eIF3L
- Top Cited PapersOpen Access
- 20 May 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1)
Akkermansia muciniphila attenuates intervertebral disc degeneration via extracellular vesicle-mediated delivery of the effector protein B2UKX5
Low back pain is a leading cause of global disability, with intervertebral disc degeneration (IVDD) as a primary contributor. Emerging evidence suggests a link between gut microbiota and disc health, yet the underlying mechanisms remain unclear. Through Mendelian randomization and a clinical cohort analysis, we identified a causal inverse relationship between Akkermansia muciniphila ( Akk ) abundance and IVDD risk, with reduced fecal Akk levels correlating with increased IVDD severity. Akk protected against IVDD in microbiota-depleted mice, and this protection was abolished by pharmacologic inhibition of extracellular vesicle (EV) secretion. Consistently, Akk -derived EVs ( Akk -EVs) recapitulated the benefits of Akk across natural aging, tail needle puncture, and bipedal standing mouse models, while control bacterium ( Escherichia coli ) and its EVs did not. Proteomics and functional validation identified B2UKX5 as a key Akk -EV-enriched effector protein. Furthermore, recombinant B2UKX5 attenuated IVDD in vivo and regulated critical pathways for disc homeostasis, including collagen synthesis, extracellular matrix remodeling, and chromatin silencing, as revealed by transcriptomic profiling of microdissected nucleus pulposus and annulus fibrosus tissues. Analysis of clinical samples further confirmed that Akk -EVs and B2UKX5 levels in circulation and intervertebral disc tissues were negatively correlated with IVDD severity. These findings establish a novel gut-disc axis, highlighting Akk , Akk -EVs, and B2UKX5 as promising therapeutic candidates for IVDD prevention and treatment.
- 20 May 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1)
Top Cited PapersOpen AccessAkkermansia muciniphila attenuates intervertebral disc degeneration via extracellular vesicle-mediated delivery of the effector protein B2UKX5
Low back pain is a leading cause of global disability, with intervertebral disc degeneration (IVDD) as a primary contributor. Emerging evidence suggests a link between gut microbiota and disc health, yet the underlying mechanisms remain unclear. Through Mendelian randomization and a clinical cohort analysis, we identified a causal inverse relationship between Akkermansia muciniphila ( Akk ) abundance and IVDD risk, with reduced fecal Akk levels correlating with increased IVDD severity. Akk protected against IVDD in microbiota-depleted mice, and this protection was abolished by pharmacologic inhibition of extracellular vesicle (EV) secretion. Consistently, Akk -derived EVs ( Akk -EVs) recapitulated the benefits of Akk across natural aging, tail needle puncture, and bipedal standing mouse models, while control bacterium ( Escherichia coli ) and its EVs did not. Proteomics and functional validation identified B2UKX5 as a key Akk -EV-enriched effector protein. Furthermore, recombinant B2UKX5 attenuated IVDD in vivo and regulated critical pathways for disc homeostasis, including collagen synthesis, extracellular matrix remodeling, and chromatin silencing, as revealed by transcriptomic profiling of microdissected nucleus pulposus and annulus fibrosus tissues. Analysis of clinical samples further confirmed that Akk -EVs and B2UKX5 levels in circulation and intervertebral disc tissues were negatively correlated with IVDD severity. These findings establish a novel gut-disc axis, highlighting Akk , Akk -EVs, and B2UKX5 as promising therapeutic candidates for IVDD prevention and treatment.
- 5 January 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (2) , 329-348
Brain neuron-derived WDFY1 induces bone loss
Brain health is closely linked to bone homeostasis. Skeletal aging is characterized by inadequate bone formation and marrow adiposity, but whether the brain contributes to this imbalance remains unknown. This study shows that aged brain neurons, mainly those in the hippocampus and cerebral cortex, produce excess WD repeat and FYVE domain containing 1 (WDFY1) protein and transfer it to the bone via extracellular vesicles (EVs), leading to bone-fat imbalance and osteoporosis. Increasing brain Wdfy1 expression causes premature skeletal aging. Conversely, suppressing Wdfy1 in the whole brain, hippocampus or neurons, genetically deleting neuronal Wdfy1, and selectively inhibiting neuronal EV release all improve bone health. Mechanistically, WDFY1 binds to the retromer complex to promote the endosome-to-Golgi recycling of cathepsin D and peroxiredoxin 2, thus inhibiting osteogenesis and augmenting adipogenesis. This study identifies the role of aged brain neuronal EVs as an important messenger in triggering bone-fat imbalance by transferring WDFY1 to bone.
- 5 January 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (2) , 329-348
Brain neuron-derived WDFY1 induces bone loss
Brain health is closely linked to bone homeostasis. Skeletal aging is characterized by inadequate bone formation and marrow adiposity, but whether the brain contributes to this imbalance remains unknown. This study shows that aged brain neurons, mainly those in the hippocampus and cerebral cortex, produce excess WD repeat and FYVE domain containing 1 (WDFY1) protein and transfer it to the bone via extracellular vesicles (EVs), leading to bone-fat imbalance and osteoporosis. Increasing brain Wdfy1 expression causes premature skeletal aging. Conversely, suppressing Wdfy1 in the whole brain, hippocampus or neurons, genetically deleting neuronal Wdfy1, and selectively inhibiting neuronal EV release all improve bone health. Mechanistically, WDFY1 binds to the retromer complex to promote the endosome-to-Golgi recycling of cathepsin D and peroxiredoxin 2, thus inhibiting osteogenesis and augmenting adipogenesis. This study identifies the role of aged brain neuronal EVs as an important messenger in triggering bone-fat imbalance by transferring WDFY1 to bone.
- Open Access
- 20 October 2025
- Published by Springer Nature in Research Square
First-in-Human, Open-Label, Within-Patient Controlled Study to Evaluate an Extensively Humanized Porcine Donor
Recent human decedent model studies and compassionate xenograft use have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation, and long-term life-supporting function of organs from selectively germline genome-edited pigs (SGGEP) with 11 genomic modifications. These modifications eliminated glycan xenoantigens, overexpressed human transgenes, and enhanced immunological and coagulation compatibility with human biology. In vitro analyses showed SGGEP cells possessed immunological tolerance and coagulation compatibility similar to human cells. In nonhuman primate models, kidney grafts sustained function for 447 days, and cardiac grafts survived healthily for at least 160 days. Skin grafts demonstrated life-supporting capabilities in a lethal skin removal model, facilitating complete wound closure and promoting autologous skin regeneration, remaining viable for ≥25 days without immune suppression. A clinical trial involving 31 patients with thermal burns showed that SGGEP skin grafts achieved complete and durable wound closure, with three cases not requiring autografting. These findings underscore the potential of SGGEP xenotransplantation in addressing donor organ scarcity and highlight the "one pig fits all" strategy as a promising solution for broader applications in human transplantation.
- 20 October 2025
- Published by Springer Nature in Research Square
Open AccessFirst-in-Human, Open-Label, Within-Patient Controlled Study to Evaluate an Extensively Humanized Porcine Donor
Recent human decedent model studies and compassionate xenograft use have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation, and long-term life-supporting function of organs from selectively germline genome-edited pigs (SGGEP) with 11 genomic modifications. These modifications eliminated glycan xenoantigens, overexpressed human transgenes, and enhanced immunological and coagulation compatibility with human biology. In vitro analyses showed SGGEP cells possessed immunological tolerance and coagulation compatibility similar to human cells. In nonhuman primate models, kidney grafts sustained function for 447 days, and cardiac grafts survived healthily for at least 160 days. Skin grafts demonstrated life-supporting capabilities in a lethal skin removal model, facilitating complete wound closure and promoting autologous skin regeneration, remaining viable for ≥25 days without immune suppression. A clinical trial involving 31 patients with thermal burns showed that SGGEP skin grafts achieved complete and durable wound closure, with three cases not requiring autografting. These findings underscore the potential of SGGEP xenotransplantation in addressing donor organ scarcity and highlight the "one pig fits all" strategy as a promising solution for broader applications in human transplantation.
- Open Access
- 16 January 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-12
Fasting activates optineurin-mediated mitophagy in chondrocytes to protect against osteoarthritis
Mitochondrial homeostasis plays a crucial role in the pathogenesis of osteoarthritis (OA), a chronic musculoskeletal disorder characterized by articular cartilage degeneration and chondrocyte apoptosis. However, molecular mechanisms underlying the association between mitophagy and OA remain unclear. Here, we aimed to investigate the role of the autophagy receptor protein optineurin (OPTN) in OA, and explore the effects of dietary intervention on OA symptoms and its relationship with OPTN-mediated mitophagy. Our findings showed the downregulation of OPTN in patients with OA. Using an Optn-knockout mouse model, we demonstrated that OPTN deficiency leads to impaired mitophagy, resulting in the accumulation of damaged mitochondria, increased production of reactive oxygen species, and chondrocyte apoptosis. Furthermore, fasting prevented OA progression by activating OPTN-mediated mitophagy and maintaining mitochondrial homeostasis in mice. The present study revealed a novel mechanism by which OPTN-mediated mitophagy influences chondrocytes and the OA phenotype in Optn-knockout mice, suggesting that OPTN-mediated mitophagy plays a crucial role in OA development and progression. This study provides new insights into the pathogenesis of OA and offers a potential avenue for the development of novel drugs targeting OPTN to mitigate OA progression.
- 16 January 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-12
Open AccessFasting activates optineurin-mediated mitophagy in chondrocytes to protect against osteoarthritis
Mitochondrial homeostasis plays a crucial role in the pathogenesis of osteoarthritis (OA), a chronic musculoskeletal disorder characterized by articular cartilage degeneration and chondrocyte apoptosis. However, molecular mechanisms underlying the association between mitophagy and OA remain unclear. Here, we aimed to investigate the role of the autophagy receptor protein optineurin (OPTN) in OA, and explore the effects of dietary intervention on OA symptoms and its relationship with OPTN-mediated mitophagy. Our findings showed the downregulation of OPTN in patients with OA. Using an Optn-knockout mouse model, we demonstrated that OPTN deficiency leads to impaired mitophagy, resulting in the accumulation of damaged mitochondria, increased production of reactive oxygen species, and chondrocyte apoptosis. Furthermore, fasting prevented OA progression by activating OPTN-mediated mitophagy and maintaining mitochondrial homeostasis in mice. The present study revealed a novel mechanism by which OPTN-mediated mitophagy influences chondrocytes and the OA phenotype in Optn-knockout mice, suggesting that OPTN-mediated mitophagy plays a crucial role in OA development and progression. This study provides new insights into the pathogenesis of OA and offers a potential avenue for the development of novel drugs targeting OPTN to mitigate OA progression.
- Open Access
- 8 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (34) , e2400196
Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis
Osteoarthritis is a highly prevalent progressive joint disease that still requires an optimal therapeutic approach. Intermittent fasting is an attractive dieting strategy for improving health. Here this study shows that intermittent fasting potently relieves medial meniscus (DMM)‐ or natural aging‐induced osteoarthritic phenotypes. Osteocytes, the most abundant bone cells, secrete excess neuropeptide Y (NPY) during osteoarthritis, and this alteration can be altered by intermittent fasting. Both NPY and the NPY‐abundant culture medium of osteocytes (OCY‐CM) from osteoarthritic mice possess pro‐inflammatory, pro‐osteoclastic, and pro‐neurite outgrowth effects, while OCY‐CM from the intermittent fasting‐treated osteoarthritic mice fails to induce significant stimulatory effects on inflammation, osteoclast formation, and neurite outgrowth. Depletion of osteocyte NPY significantly attenuates DMM‐induced osteoarthritis and abolishes the benefits of intermittent fasting on osteoarthritis. This study suggests that osteocyte NPY is a key contributing factor in the pathogenesis of osteoarthritis and intermittent fasting represents a promising nonpharmacological antiosteoarthritis method by targeting osteocyte NPY.
- 8 July 2024
- Published by Wiley in Advanced Science
- Vol. 11 (34) , e2400196
Open AccessIntermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis
Osteoarthritis is a highly prevalent progressive joint disease that still requires an optimal therapeutic approach. Intermittent fasting is an attractive dieting strategy for improving health. Here this study shows that intermittent fasting potently relieves medial meniscus (DMM)‐ or natural aging‐induced osteoarthritic phenotypes. Osteocytes, the most abundant bone cells, secrete excess neuropeptide Y (NPY) during osteoarthritis, and this alteration can be altered by intermittent fasting. Both NPY and the NPY‐abundant culture medium of osteocytes (OCY‐CM) from osteoarthritic mice possess pro‐inflammatory, pro‐osteoclastic, and pro‐neurite outgrowth effects, while OCY‐CM from the intermittent fasting‐treated osteoarthritic mice fails to induce significant stimulatory effects on inflammation, osteoclast formation, and neurite outgrowth. Depletion of osteocyte NPY significantly attenuates DMM‐induced osteoarthritis and abolishes the benefits of intermittent fasting on osteoarthritis. This study suggests that osteocyte NPY is a key contributing factor in the pathogenesis of osteoarthritis and intermittent fasting represents a promising nonpharmacological antiosteoarthritis method by targeting osteocyte NPY.
- Open Access
- 20 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Reassessing endothelial-to-mesenchymal transition in mouse bone marrow: insights from lineage tracing models
Endothelial cells (ECs) and bone marrow stromal cells (BMSCs) play crucial roles in supporting hematopoiesis and hematopoietic regeneration. However, whether ECs are a source of BMSCs remains unclear. Here, we evaluate the contribution of endothelial-to-mesenchymal transition to BMSC generation in postnatal mice. Single-cell RNA sequencing identifies ECs expressing BMSC markers Prrx1 and Lepr; however, this could not be validated using Prrx1-Cre and Lepr-Cre transgenic mice. Additionally, only a minority of BMSCs are marked by EC lineage tracing models using Cdh5-rtTA-tetO-Cre or Tek-CreERT2. Moreover, Cdh5+ BMSCs and Tek+ BMSCs show distinct spatial distributions and characteristic mesenchymal markers, suggestive of their origination from different progenitors rather than CDH5+ TEK+ ECs. Furthermore, myeloablation induced by 5-fluorouracil treatment does not increase Cdh5+ BMSCs. Our findings indicate that ECs hardly convert to BMSCs during homeostasis and myeloablation-induced hematopoietic regeneration, highlighting the importance of using appropriate genetic models and conducting careful data interpretation in studies concerning endothelial-to-mesenchymal transition.
- 20 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessReassessing endothelial-to-mesenchymal transition in mouse bone marrow: insights from lineage tracing models
Endothelial cells (ECs) and bone marrow stromal cells (BMSCs) play crucial roles in supporting hematopoiesis and hematopoietic regeneration. However, whether ECs are a source of BMSCs remains unclear. Here, we evaluate the contribution of endothelial-to-mesenchymal transition to BMSC generation in postnatal mice. Single-cell RNA sequencing identifies ECs expressing BMSC markers Prrx1 and Lepr; however, this could not be validated using Prrx1-Cre and Lepr-Cre transgenic mice. Additionally, only a minority of BMSCs are marked by EC lineage tracing models using Cdh5-rtTA-tetO-Cre or Tek-CreERT2. Moreover, Cdh5+ BMSCs and Tek+ BMSCs show distinct spatial distributions and characteristic mesenchymal markers, suggestive of their origination from different progenitors rather than CDH5+ TEK+ ECs. Furthermore, myeloablation induced by 5-fluorouracil treatment does not increase Cdh5+ BMSCs. Our findings indicate that ECs hardly convert to BMSCs during homeostasis and myeloablation-induced hematopoietic regeneration, highlighting the importance of using appropriate genetic models and conducting careful data interpretation in studies concerning endothelial-to-mesenchymal transition.
- Open Access
- 15 December 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (3) , 1166-1186
Extracellular vesicles from human urine-derived stem cells delay aging through the transfer of PLAU and TIMP1
- 15 December 2023
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (3) , 1166-1186
Open AccessExtracellular vesicles from human urine-derived stem cells delay aging through the transfer of PLAU and TIMP1